An Evidence-based Approach to Controlling Drug Costs
Optimizing the dosing of many expensive drugs can drastically reduce both costs and toxicities. The Federal Government, state governments, employers, and individual patients could collectively save tens of billions of dollars each year by simply optimizing the dosing of the most expensive prescription drugs on the market, particularly in oncology. Optimized dosing can also improve health outcomes. The next administration should, therefore, launch an effort to control the cost of prescription drugs through an evidence-based approach to optimizing drug dosing and improving outcomes. The requisite trials pay for themselves in immediate cost savings.
Inconsistent data collection makes disaster resilience more challenging than it needs to be. By opening up and making this data consistent, the Biden-Harris Administration can change the way we prepare and mitigate disaster for the better.
The Wildland Fire Mitigation and Management Commission called for input from diverse stakeholders and FAS, along with partners Conservation X Labs (CXL), COMPASS, and the California Council on Science and Technology (CCST), answered the call. Recruiting participants from academia, the private sector, national labs, and other nonprofits, the Wildland Fire Policy Accelerator produced 24 ideas […]
The U.S. is facing a shortage in both pilot-scale and manufacturing-scale biomanufacturing facilities that severely hinders product development and commercialization.
The space economy is enormous, but one of its biggest challenges is tiny: space debris.